Late Phase Market Outlook: 2018-2022
$4,460.00 – $8,920.00
Related products
-
CRO Quality Benchmarking – Phase II/III Service Providers (4th edition)
$6,800.00 – $13,600.00 -
Late Phase Market Overview and Outlook (2013)
$4,900.00 – $9,800.00 -
Improving Patient Recruitment in Biosimilar Trials
$3,260.00 – $6,520.00 -
Social Media: Best Practices and Strategic Use in Patient Recruitment
$4,900.00 – $9,800.00